Icon
Icon

Discovery

Program of research will focus on utilising the existing capacity, scientific talent, and ingenuity in sub-Saharan Africa to advance the HIV vaccine field

Icon

Africa-Centric

Partners in the consortium are from 8 African countries viz. South Africa, Nigeria, Kenya, Mozambique, Tanzania, Uganda, Zambia and Zimbabwe

Icon

Female Led

Mainly female scientists from Africa will lead the discovery, design and testing of HIV vaccine candidates

About Us

BRILLIANT Consortium

The BRILLIANT Consortium (BRinging Innovation to cLinical and Laboratory research to end HIV In Africa through New vaccine Technology), is a Cooperative Agreement with the US Agency for International Development and kicked off in September 2023. 

BRILLIANT constitutes a multi-disciplinary collaboration with partners and collaborators from Nigeria, Uganda, Kenya, Tanzania, Zimbabwe, Zambia, Mozambique, South Africa and Internationally with the overall objective of developing and evaluating HIV vaccine candidates emanating from the African continent.

8

African

Countries

Read More

Vision, Mission & Aim